0.916
-0.10 (-10.24%)
| 前收盘价格 | 1.02 |
| 收盘价格 | 1.02 |
| 成交量 | 645,934 |
| 平均成交量 (3个月) | 1,076,006 |
| 市值 | 31,634,156 |
| 价格/销量 (P/S) | 0.360 |
| 股市价格/股市净资产 (P/B) | 0.920 |
| 52周波幅 | |
| 利润日期 | 16 Apr 2025 |
| 营业毛利率 | -28.26% |
| 营业利益率 (TTM) | -6.08% |
| 稀释每股收益 (EPS TTM) | -1.09 |
| 季度收入增长率 (YOY) | -6.00% |
| 总债务/股东权益 (D/E MRQ) | 49.51% |
| 流动比率 (MRQ) | 1.05 |
| 营业现金流 (OCF TTM) | -4.49 M |
| 杠杆自由现金流 (LFCF TTM) | -1.94 M |
| 资产报酬率 (ROA TTM) | -14.90% |
| 股东权益报酬率 (ROE TTM) | -50.03% |
市场趋势
| 短期 | 中期 | ||
| 行业 | Medical Distribution (US) | 混合的 | 混合的 |
| Medical Distribution (全球的) | 看涨 | 混合的 | |
| 股票 | Cosmos Health Inc. | - | - |
AIStockmoo 评分
| 分析师共识 | 0.0 |
| 内部交易活动 | NA |
| 价格波动 | -4.5 |
| 技术平均移动指标 | -3.5 |
| 技术振荡指标 | -0.5 |
| 平均 | -2.13 |
|
Cosmos Health Inc is engaged in the nutraceuticals sector through its own proprietary lines of products 'Sky Premium Life' and 'Mediterranation'. Additionally, the firm is operating in the pharmaceutical sector through the provision of a broad line of branded over-the-counter drugs and branded and generic medicines. The company's focus will be on Branded Pharmaceuticals, Over-the-Counter medicines, and Generic Pharmaceuticals. It provides its products to wholesale drug distributors, wholesalers, and retail healthcare providers. The company's segment are Wholesale, Pharma Manufacturing, Nutraceuticals & Pharmaceuticals and Other. It derives maximum revenue from Wholesale Segment. |
|
| 部门 | Healthcare |
| 行业 | Medical Distribution |
| 投资方式 | Small Value |
| 内部持股比例 | 31.08% |
| 机构持股比例 | 9.46% |
该时间范围内无数据。
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合